The Q2 beat was modest and overshadowed by YoY earnings decline and margin compression. The new 3870 pump launch and Q3 guidance suggest H2 ramp; monitor Q3 results for confirmation of inflection. The maintained full-year guidance implies confidence in acceleration, but execution risk remains.
Price Chart
Executive Summary
iRadimed reported Q2 2026 revenue of $20.5M (slightly above $20.4M consensus) and non-GAAP EPS of $0.46 (beat $0.44 estimate by 4.5%). However, GAAP EPS declined 9% YoY to $0.41, gross margin compressed to 74% from 78%, and operating cash flow fell 23%. The company reaffirmed full-year 2026 guidance and issued Q3 revenue guidance of $23-24.5M, signaling an expected H2 ramp from the new 3870 pump launch.
Key Financial Metrics
Key Facts
- Q2 2026 revenue $20.5M (+0.5% YoY) vs consensus $20.4M
- Non-GAAP diluted EPS $0.46 vs consensus $0.44 (+4.5% beat)
- GAAP diluted EPS $0.41 vs $0.45 YoY (-9%)
- Gross margin 74% vs 78% YoY
- Operating cash flow $5.9M vs $7.7M YoY (-23%)
- Q3 2026 guidance: revenue $23.0-24.5M, non-GAAP EPS $0.54-0.59
- Full-year 2026 guidance reaffirmed: revenue $91-96M, non-GAAP EPS $2.09-2.24
- New 3870 MR IV pump launch underway; >70% of new pump orders for quad-stack configuration
- Quarterly cash dividend of $0.20 per share declared
Financial Impact
Revenue slightly above consensus, but earnings declined YoY; Q3 guidance implies H2 acceleration with new product ramp
Risk Factors
- New product ramp execution and manufacturing efficiency
- Gross margin pressure from product transition and startup costs
- Competitive dynamics in MRI-compatible devices
- Dependence on limited product lines
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3336764 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 31, 2026 12w ago | 8-K | $90.86 $84.63 | ▼ −6.86% | ▼ −9.31% | $84.26 (−7.26%) |
Jul 31, 2026 12w ago | Press Release | $90.86 $84.63 | ▼ −6.86% | ▼ −9.31% | $84.26 (−7.26%) |
Jul 24, 2026 13w ago | Press Release | $95.08 $87.65 | ▼ −7.81% | ▼ −11.52% | $84.26 (−11.38%) |
Jun 4, 2026 20w ago | Insider Cluster | $93.07 $86.38 | ▼ −7.19% | ▼ −11.19% | $84.26 (−9.47%) |
May 20, 2026 22w ago | Press Release | $90.40 $86.95 | ▼ −3.82% | ▼ −8.82% | $84.26 (−6.79%) |
May 1, 2026 25w ago | Press Release | $87.15 $94.83 | ▲ +8.81% | ▲ +5.74% | $84.26 (−3.32%) |
Apr 27, 2026 26w ago | Press Release | $89.08 $94.08 | ▲ +5.61% | ▲ +0.84% | $84.26 (−5.41%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers